» Articles » PMID: 1467138

Reduction of Plasma Cholesterol by Lovastatin Normalizes Erythrocyte Membrane Fluidity in Patients with Severe Hypercholesterolaemia

Overview
Specialty Pharmacology
Date 1992 Nov 1
PMID 1467138
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of lovastatin on erythrocyte membrane composition and fluidity was investigated in eight patients with severe hypercholesterolaemia (mean LDL-cholesterol of 7.2 mmol l-1). Lovastatin was administered at a dosage of 40-80 mg for 20 weeks and was discontinued for 5 weeks thereafter. Parallel to a 47% fall in plasma LDL cholesterol, there was a significant reduction (P < 0.01) in erythrocyte membrane cholesterol:phospholipid molar ratio, while erythrocyte membrane fluidity assessed by diphenylhexatriene (DPH) fluorescence polarization increased significantly (P < 0.01). Discontinuation of lovastatin resulted in the reversal of erythrocyte membrane composition and fluidity to pre-treatment values.

Citing Articles

Statin-mediated reduction in mitochondrial cholesterol primes an anti-inflammatory response in macrophages by upregulating Jmjd3.

Salloum Z, Dauner K, Li Y, Verma N, Valdivieso-Gonzalez D, Almendro-Vedia V Elife. 2024; 13.

PMID: 38602170 PMC: 11186637. DOI: 10.7554/eLife.85964.


Phosphatidylethanolamine Is a Key Regulator of Membrane Fluidity in Eukaryotic Cells.

Dawaliby R, Trubbia C, Delporte C, Noyon C, Ruysschaert J, Van Antwerpen P J Biol Chem. 2015; 291(7):3658-67.

PMID: 26663081 PMC: 4751403. DOI: 10.1074/jbc.M115.706523.


Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study [corrected].

Schaffer A, Verdoia M, Cassetti E, Barbieri L, Perrone-Filardi P, Marino P J Thromb Thrombolysis. 2015; 40(1):61-8.

PMID: 25680891 DOI: 10.1007/s11239-015-1174-x.


The effects of atorvastatin therapy on rheological characteristics of erythrocyte membrane, serum lipid profile and oxidative status in patients with dyslipidemia.

Uydu H, Yildirmis S, Orem C, Calapoglu M, Alver A, Kural B J Membr Biol. 2012; 245(11):697-705.

PMID: 22706680 DOI: 10.1007/s00232-012-9441-7.


Influence of the use of statin on the stability of erythrocyte membranes in multiple sclerosis.

de Freitas M, de Oliveira M, Santos D, Mascarenhas Netto R, Fenelon S, Penha-Silva N J Membr Biol. 2010; 233(1-3):127-34.

PMID: 20146058 DOI: 10.1007/s00232-010-9232-y.


References
1.
Cooper R, Arner E, Wiley J, Shattil S . Modification of red cell membrane structure by cholesterol-rich lipid dispersions. A model for the primary spur cell defect. J Clin Invest. 1975; 55(1):115-26. PMC: 301723. DOI: 10.1172/JCI107901. View

2.
Cooper R, Leslie M, Fischkoff S, Shinitzky M, Shattil S . Factors influencing the lipid composition and fluidity of red cell membranes in vitro: production of red cells possessing more than two cholesterols per phospholipid. Biochemistry. 1978; 17(2):327-31. DOI: 10.1021/bi00595a021. View

3.
Levin G, Cogan U, Levy Y, Mokady S . Riboflavin deficiency and the function and fluidity of rat erythrocyte membranes. J Nutr. 1990; 120(8):857-61. DOI: 10.1093/jn/120.8.857. View

4.
Schuff-Werner P, Schutz E, Seyde W, Eisenhauer T, Janning G, Armstrong V . Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). Eur J Clin Invest. 1989; 19(1):30-7. DOI: 10.1111/j.1365-2362.1989.tb00192.x. View

5.
Schick B, Schick P . The effect of hypercholesterolemia on guinea pig platelets, erythrocytes and megakaryocytes. Biochim Biophys Acta. 1985; 833(2):291-302. DOI: 10.1016/0005-2760(85)90201-2. View